PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Research, General Hospital of Zone No. 1 IMSS, Villa de Alvarez, Colima 28984, Mexico.\', \'Department of Molecular Medicine, School of Medicine, University of Colima, Colima 28040, Mexico.\', \'Department of Research, Foundation for Cancer Ethics, Education and Research of the Cancerology State Institute, Colima 28085, Mexico.\', \'Laboratory of Molecular and Structural Physiology, School of Biological Sciences, Universidad Autónoma de Nuevo León, San Nicolas de los Garza, Nuevo León 66455, Mexico.\', \'Molecular Medicine Laboratory, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas 98160, Mexico.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3892/ijmm.2022.508429
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular medicine
is ?:pmid of
?:pmid
?:pmid
  • 35029292
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.992
?:rankingScore_hIndex
  • 78
is ?:relation_isRelatedTo_publication of
?:title
  • Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35029292>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35029292>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all